论文部分内容阅读
目的 :探讨内分泌综合治疗老年内分泌失调性骨质疏松症的临床疗效。方法 :选取2015年11月-2016年11月在医院进行治疗的老年内分泌失调性骨质疏松症患者96例为研究对象,给予96例患者药物治疗,并根据药物的不同分为观察组与对照组,对照组患者采用常规药物治疗,共48例患者,观察组患者采用内分泌综合疗法治疗,共48例患者,对两组患者的各项临床症状和体征的变化情况进行观察和记录,分析比较两组患者临床疗效情况、各项指标变化情况。结果 :观察组总有效率为95.83%相比于对照组的79.17%,观察组明显更高,组间比较,差异具有统计学意义(P<0.05);治疗前,两组患者各项指标变化情况进行比较,组间差异无统计学意义(P<0.05);治疗后,观察组患者各项指标的改善程度相比于对照组,观察组更好,组间比较,差异具有统计学意义(P<0.05)。结论 :内分泌综合治疗老年内分泌失调性骨质疏松症的临床疗效非常好,患者的各项临床症状、体征和生活质量得到了很大程度的改善,治愈率和安全性得到了提高,临床上值得应用推广。
Objective: To investigate the clinical effect of endocrine comprehensive treatment of senile endocrine disorders osteoporosis. Methods: A total of 96 elderly patients with endocrine disorders of osteoporosis who were treated in the hospital from November 2015 to November 2016 were enrolled in this study. Drug treatment was given to 96 patients and divided into observation group and control group 48 patients in the observation group were treated by endocrine therapy. A total of 48 patients were observed and recorded on the changes of clinical symptoms and signs of the two groups. Analysis and comparison Clinical efficacy of two groups of patients, the changes in various indicators. Results: The total effective rate was 95.83% in the observation group compared with 79.17% in the control group, the observation group was significantly higher, the difference between the two groups was statistically significant (P <0.05); before treatment, (P <0.05). After treatment, the improvement degree of each index in the observation group was better than that in the control group and the observation group, and the difference was statistically significant (P <0.05) P <0.05). Conclusion: Endocrine comprehensive treatment of elderly patients with endocrine disorders of osteoporosis clinical efficacy is very good, the patient’s clinical symptoms, signs and quality of life has been greatly improved, the cure rate and safety has been improved, clinically worth Application promotion.